NewAmsterdam Pharma News, NewAmsterdam Pharma Quote, NAMS Quote

NewAmsterdam Pharma (NQ:NAMS) Delayed: 9.25 +0.13 (1.43%)

Prev. Close

$9.12

Open

$9.24

52 Wk High

$0.00

52 Wk Low

$0.00

Day High

$9.75

Day Low

$9.00

P/E

N/A

EPS

$0.00

Volume

13,888

Friends, Peers and Foes (?): NAMSW, FLAC, FRBN, FLACU, VECT (more...)

Sep 25, 2023 08:11 AM Form 6-K NewAmsterdam Pharma Co For: Sep 25
Sep 21, 2023 07:19 AM Form 424B3 NewAmsterdam Pharma Co
Sep 21, 2023 07:15 AM Form 6-K NewAmsterdam Pharma Co For: Sep 21
Sep 21, 2023 07:00 AM NewAmsterdam Pharma (NAMS) Announces Initial Data from Phase 2a Clinical Trial of Obicetrapib
Sep 21, 2023 07:00 AM NewAmsterdam Pharma Announces Initial Data from Phase 2a Clinical Trial Evaluating Obicetrapib in Patients with Early Alzheimer’s Disease Who Carry an ApoE4 Mutation
Sep 20, 2023 08:00 AM NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
Sep 20, 2023 06:03 AM Form SC 13G/A NewAmsterdam Pharma Co Filed by: Morningside Venture Investments Ltd
Aug 28, 2023 04:16 PM Form 6-K NewAmsterdam Pharma Co For: Aug 28
Aug 15, 2023 04:53 PM Form 424B3 NewAmsterdam Pharma Co
Aug 15, 2023 04:03 PM Form SC 13D/A NewAmsterdam Pharma Co Filed by: Frazier Life Sciences X, L.P.

Entities mentioned with NAMS